# Natali Goginashvili Natali represents and advises clients on all aspects of intellectual property law, with a particular focus on patent litigation, often in cases with an international dimension. She also assists clients in trademark disputes, unfair competition, and parasitism, as well as regulatory matters in the healthcare and life sciences sectors. Before joining the firm in September 2024, Natali gained broad experience through internships at international and European law firms, as well as in the Patent Department of the pharmaceutical company Sanofi. She also developed a global and strategic understanding of the patent system while working in the Intellectual Property, Public Procurement, and Competition Division of the World Trade Organization (WTO). ### Representative matters - Coordinating global patent infringement proceedings involving multiple patents for a flagship product of a major pharmaceutical company. - Assisting a pharmaceutical company in a patent infringement action based on regulatory exclusivity. - Negotiating and drafting patent and regulatory rights license agreements for a blockbuster pharmaceutical product. - Advising a major pharmaceutical company on the protection of rights related to second medical use of drugs. ### Professional affiliations - International Association for the Protection of Intellectual Property (AIPPI) - Association of European Patent Practitioners (APEB) ### Publications - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview IV, GRUR Patent 03/2025 (pp. 106ff.) - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview V, GRUR Patent 06/2025 (pp. 281ff.) - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview VI, GRUR Patent 09/2025 (pp. 434ff.) - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview VII, GRUR Patent 12/2025 (pp. 579ff.) - ”[The Unified Patent Court – A case law overview III](https://www.hoyngrokhmonegier.com/news-insights/the-unified-patent-court-a-case-law-overview-iii/)” – GRUR Patent 2024 - “[Clash of the Titans: Conflict between the Regulatory and Patent Law Systems Around Second Medical Use Claims](https://academic.oup.com/jiplp/article/16/2/136/6135626?guestAccessKey=4193ddd7-109c-4055-9022-ffaceb1c67d1)” – JIPLP, Oxford University Press, Feb. 2021 - [“La licence d’office, alternative efficace à la levée de brevet sur les vaccins Covid-19?”](https://www.lexis360intelligence.fr/revues/Propri%C3%A9t%C3%A9_industrielle/PNO_RPRIND/document/PS_KPRE-618795_0KTV?doc_type=doctrine_revue&source=autocompletion) – Revue de la propriété industrielle, Lexisnexis, August 2021 ### Speaking engagements - Speaker at APEB “Remuneration of salaried inventors (2018 -2023)”, Sept. 2023. - Lecturer at Université Paris-Saclay for the Master 2 in Pharmacy (DEIM), subject: “Drug development and Industrial Property”, dec. 2023. - Speaker at the “International Colloquium of Professors of Intellectual Property Law” (WIPO & WTO), Nov. 2022. - Speaker at the “TRIPS and Public Health” workshop for LDC ambassadors at the WTO, Sept. 2022. ### Representative matters - Coordinating global patent infringement proceedings involving multiple patents for a flagship product of a major pharmaceutical company. - Assisting a pharmaceutical company in a patent infringement action based on regulatory exclusivity. - Negotiating and drafting patent and regulatory rights license agreements for a blockbuster pharmaceutical product. - Advising a major pharmaceutical company on the protection of rights related to second medical use of drugs. ## Professional affiliations - International Association for the Protection of Intellectual Property (AIPPI) - Association of European Patent Practitioners (APEB) ## Publications - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview IV, GRUR Patent 03/2025 (pp. 106ff.) - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview V, GRUR Patent 06/2025 (pp. 281ff.) - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview VI, GRUR Patent 09/2025 (pp. 434ff.) - Haft/Agé/Otten/Goginashvili/Fourmaux in: The Unified Patent Court – a case law overview VII, GRUR Patent 12/2025 (pp. 579ff.) - ”[The Unified Patent Court – A case law overview III](https://www.hoyngrokhmonegier.com/news-insights/the-unified-patent-court-a-case-law-overview-iii/)” – GRUR Patent 2024 - “[Clash of the Titans: Conflict between the Regulatory and Patent Law Systems Around Second Medical Use Claims](https://academic.oup.com/jiplp/article/16/2/136/6135626?guestAccessKey=4193ddd7-109c-4055-9022-ffaceb1c67d1)” – JIPLP, Oxford University Press, Feb. 2021 - [“La licence d’office, alternative efficace à la levée de brevet sur les vaccins Covid-19?”](https://www.lexis360intelligence.fr/revues/Propri%C3%A9t%C3%A9_industrielle/PNO_RPRIND/document/PS_KPRE-618795_0KTV?doc_type=doctrine_revue&source=autocompletion) – Revue de la propriété industrielle, Lexisnexis, August 2021 ## Speaking engagements - Speaker at APEB “Remuneration of salaried inventors (2018 -2023)”, Sept. 2023. - Lecturer at Université Paris-Saclay for the Master 2 in Pharmacy (DEIM), subject: “Drug development and Industrial Property”, dec. 2023. - Speaker at the “International Colloquium of Professors of Intellectual Property Law” (WIPO & WTO), Nov. 2022. - Speaker at the “TRIPS and Public Health” workshop for LDC ambassadors at the WTO, Sept. 2022.